EcoDrugPlus

Ensembl ID : ENSCMIG00000001836
Gene Symbol: -
Cross references: -
223 Possible Orthologues:

Ensembl ID : ENSCMIG00000001588
Gene Symbol: -
Cross references: -
172 Possible Orthologues:

Ensembl ID : ENSCMIG00000006170
Gene Symbol: -
Cross references: -
195 Possible Orthologues:

Ensembl ID : ENSCMIG00000000624
Gene Symbol: -
Cross references: -
223 Possible Orthologues:

Ensembl ID : ENSCMIG00000019771
Gene Symbol: -
Cross references: -
1334 Possible Orthologues:

Ensembl ID : ENSCMIG00000000321
Gene Symbol: -
Cross references: -
124 Possible Orthologues:

Ensembl ID : ENSCMIG00000000501
Gene Symbol: -
Cross references: -
258 Possible Orthologues:

Ensembl ID : ENSCMIG00000000583
Gene Symbol: -
Cross references: -
254 Possible Orthologues:

Ensembl ID : ENSCMIG00000001093
Gene Symbol: -
Cross references: -
208 Possible Orthologues:

Ensembl ID : ENSCMIG00000004082
Gene Symbol: -
Cross references: -
120 Possible Orthologues:

Ensembl ID : ENSCMIG00000004187
Gene Symbol: -
Cross references: -
186 Possible Orthologues:

Ensembl ID : ENSCMIG00000005336
Gene Symbol: -
Cross references: -
261 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).